Judah Folkman, DF/HCC member and director of the Vascular Biology Program at Children's Hospital Boston, died on January 14 at the age of 74. Folkman, founder of the field of angiogenesis, spent more than four decades proving that a cancer could be kept in check by cutting off its blood supply. Today, at least 50 angiogenesis inhibitors are in clinical trials around the world, and more than 1,000 laboratories in universities and industry are conducting angiogenesis research.
Children's forthcoming publication, Vector, has an article profiling the promising research that is carrying Folkman's work forward. Read the PDF article entitled, "Dr. Folkman's Progeny."